SE434397B - Sett att framstella bens-acyl-bensimidazol-2-derivat - Google Patents

Sett att framstella bens-acyl-bensimidazol-2-derivat

Info

Publication number
SE434397B
SE434397B SE7709615A SE7709615A SE434397B SE 434397 B SE434397 B SE 434397B SE 7709615 A SE7709615 A SE 7709615A SE 7709615 A SE7709615 A SE 7709615A SE 434397 B SE434397 B SE 434397B
Authority
SE
Sweden
Prior art keywords
bens
benzimidazole
acyl
derivatives
prepare
Prior art date
Application number
SE7709615A
Other languages
English (en)
Swedish (sv)
Other versions
SE7709615L (sv
Inventor
E Habicht
P G Ferrini
A Sallmann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE7709615L publication Critical patent/SE7709615L/xx
Publication of SE434397B publication Critical patent/SE434397B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/807Ketones containing a keto group bound to a six-membered aromatic ring containing halogen all halogen atoms bound to the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
SE7709615A 1976-08-27 1977-08-26 Sett att framstella bens-acyl-bensimidazol-2-derivat SE434397B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU75684A LU75684A1 (el) 1976-08-27 1976-08-27

Publications (2)

Publication Number Publication Date
SE7709615L SE7709615L (sv) 1978-02-28
SE434397B true SE434397B (sv) 1984-07-23

Family

ID=19728336

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7709615A SE434397B (sv) 1976-08-27 1977-08-26 Sett att framstella bens-acyl-bensimidazol-2-derivat

Country Status (32)

Country Link
US (3) US4141982A (el)
JP (1) JPS5328172A (el)
AR (6) AR224610A1 (el)
AT (1) AT359060B (el)
AU (1) AU517209B2 (el)
BE (1) BE858157A (el)
CA (1) CA1098526A (el)
CH (8) CH631973A5 (el)
DD (1) DD132735A5 (el)
DE (1) DE2737462A1 (el)
DK (1) DK381277A (el)
ES (7) ES461906A1 (el)
FI (1) FI68230C (el)
FR (1) FR2362841A1 (el)
GB (2) GB1595914A (el)
GR (1) GR72908B (el)
HK (1) HK93784A (el)
HU (2) HU180700B (el)
IE (1) IE45665B1 (el)
IL (1) IL52820A (el)
LU (1) LU75684A1 (el)
MY (1) MY8500936A (el)
NL (1) NL7709471A (el)
NO (1) NO148488C (el)
NZ (1) NZ185035A (el)
OA (1) OA05753A (el)
PL (4) PL112665B1 (el)
PT (1) PT66947B (el)
SE (1) SE434397B (el)
SG (1) SG70784G (el)
SU (7) SU882410A3 (el)
ZA (1) ZA775182B (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4312873A (en) * 1978-09-29 1982-01-26 Syntex (U.S.A.) Inc. 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
US4322431A (en) * 1979-02-09 1982-03-30 Ciba-Geigy Corporation Pharmaceutical preparations containing benzimidazole 2-derivatives
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles
EP0277402B1 (en) * 1987-02-03 1991-09-11 W.R. Grace & Co.-Conn. Biocide
JPH04197628A (ja) * 1990-11-28 1992-07-17 Sekisui Chem Co Ltd 壁パネルの製造方法
US5216003A (en) * 1992-01-02 1993-06-01 G. D. Searle & Co. Diacid-containing benzimidazole compounds for treatment of neurotoxic injury
FR2751649B1 (fr) * 1996-07-26 1998-08-28 Adir Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US9663703B2 (en) 2014-04-25 2017-05-30 James George Clements Method and compositions for enhanced oil recovery
CN109467512B (zh) * 2018-12-18 2021-06-08 苏州开元民生科技股份有限公司 一种3,4-二氨基-二苯甲酮的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB766749A (en) 1954-01-11 1957-01-23 Aschaffenburger Zellstoffwerke Benzimidazole cobalamines and process for their preparation and separation
US3318889A (en) * 1963-10-14 1967-05-09 S B Penick & Company 2-benzimidazole carbamates
DE1923481A1 (de) * 1969-05-08 1970-11-12 Hoechst Ag Verfahren zur Herstellung von Amiden und Estern der 1-Hydroxy-benzimidazol-2-carbonsaeure
NL7013343A (el) * 1969-09-26 1971-03-30
BE759237A (fr) * 1969-11-21 1971-05-01 Montedison Spa Procede de preparation d'amides a partir de composes heterocycliques azotes
BE792402A (fr) * 1971-12-07 1973-06-07 Ciba Geigy Composes heterocycliques azotes et medicaments anthelminthiqueset antimicrobiens qui en contiennent
US4026936A (en) * 1975-08-07 1977-05-31 Hoffmann-La Roche Inc. Anthelmintic pyridine and thiazole substituted benzimidazole carbamates

Also Published As

Publication number Publication date
GR72908B (el) 1984-01-04
ATA620677A (de) 1980-03-15
OA05753A (fr) 1981-05-31
SU745365A3 (ru) 1980-06-30
HU186765B (en) 1985-09-30
LU75684A1 (el) 1978-04-13
AR224610A1 (es) 1981-12-30
HU180700B (en) 1983-04-29
IL52820A (en) 1981-02-27
ES471686A1 (es) 1979-10-16
FR2362841B1 (el) 1981-11-20
CH631975A5 (de) 1982-09-15
ES471687A1 (es) 1979-10-16
ES8106706A1 (es) 1981-09-01
SG70784G (en) 1985-03-15
FI68230C (fi) 1985-08-12
PL110215B1 (en) 1980-07-31
NL7709471A (nl) 1978-03-01
US4213993A (en) 1980-07-22
PT66947A (en) 1977-09-01
FR2362841A1 (fr) 1978-03-24
PT66947B (en) 1979-02-07
PL112665B1 (en) 1980-10-31
SU882410A3 (ru) 1981-11-15
SU888819A3 (ru) 1981-12-07
DK381277A (da) 1978-02-28
NO148488C (no) 1983-10-19
HK93784A (en) 1984-12-07
ES461906A1 (es) 1978-12-01
FI772521A (fi) 1978-02-28
DE2737462A1 (de) 1978-03-02
SE7709615L (sv) 1978-02-28
AR222318A1 (es) 1981-05-15
AR227621A1 (es) 1982-11-30
PL108853B1 (en) 1980-05-31
MY8500936A (en) 1985-12-31
JPS5328172A (en) 1978-03-16
AU517209B2 (en) 1981-07-16
ZA775182B (en) 1978-07-26
FI68230B (fi) 1985-04-30
AU2825577A (en) 1979-03-01
AT359060B (de) 1980-10-27
ES479189A0 (es) 1981-09-01
AR230990A1 (es) 1984-08-31
ES471689A1 (es) 1979-10-16
IE45665L (en) 1978-02-27
ES471690A1 (es) 1979-10-16
GB1595914A (en) 1981-08-19
SU923368A3 (ru) 1982-04-23
AR231536A1 (es) 1984-12-28
PL105527B1 (pl) 1979-10-31
US4141982A (en) 1979-02-27
AR225889A1 (es) 1982-05-14
SU843744A3 (ru) 1981-06-30
DD132735A5 (de) 1978-10-25
CH631974A5 (de) 1982-09-15
IL52820A0 (en) 1977-10-31
NO148488B (no) 1983-07-11
SU831074A3 (ru) 1981-05-15
NZ185035A (en) 1981-05-29
ES471688A1 (es) 1979-10-16
GB1595913A (en) 1981-08-19
NO772962L (no) 1978-02-28
CA1098526A (en) 1981-03-31
SU784766A3 (ru) 1980-11-30
CH631973A5 (de) 1982-09-15
CH634305A5 (de) 1983-01-31
US4344957A (en) 1982-08-17
PL200449A1 (pl) 1978-05-22
CH632253A5 (de) 1982-09-30
BE858157A (fr) 1978-02-27
IE45665B1 (en) 1982-10-20
JPS6231706B2 (el) 1987-07-09
CH637121A5 (de) 1983-07-15
CH632749A5 (de) 1982-10-29
CH637120A5 (de) 1983-07-15

Similar Documents

Publication Publication Date Title
SE440779B (sv) Sett att framstella androstan-17-on-derivat
SE431935B (sv) Sett att framstella drageer
SE7805276L (sv) Sett att framstella liposomblandningar
SE432247B (sv) Sett att framstella dihydro-cyklosporin c
SE429551B (sv) Sett att framstella 1-(3-dimetylamino-propyl)-ftalanderivat
SE433222B (sv) Sett att framstella modifierad polysackarid
SE433819B (sv) Sett att framstella pleterade stalror
SE7606280L (sv) Sett att framstella etrar
SE441042B (sv) Sett att pavisa rheumatoida faktorer
SE435928B (sv) Sett att framstella nya 3-aryl-oxazolidin-2-oner
SE432256B (sv) Sett att framstella cellulosaalkyletrar
SE420728B (sv) Sett att framstella piperazinyliminorifamyciner
SE425736B (sv) Sett att framstella kromanon-(4)
SE427111B (sv) Sett att framstella pilokarpiniumsalter
SE430687B (sv) Sett att framstella hexanitrostilben
SE417507B (sv) Sett att framstella 2-arylamino-2-imidazolinderivat
SE7708841L (sv) Sett att framstella rifamycinforeningar
SE420732B (sv) Sett att framstella 4-gonen-3-oner
SE420602B (sv) Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat
SE436037B (sv) Sett att framstella nya 11-desoxi-prostaglandin-f?712-derivat
SE425321B (sv) Sett att reducera vanadinoxider
SE7804126L (sv) Sett att framstella vulkanisat
SE434397B (sv) Sett att framstella bens-acyl-bensimidazol-2-derivat
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE433213B (sv) Sett att framstella 2 -fenyl-3-amino-benso/b/tiofenderivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7709615-4

Effective date: 19890911

Format of ref document f/p: F